Cargando…

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma

Background: The N-acetyltransferase 1 (NAT1) gene is downregulated in several cancers and associated with patient survival. In this study, we sought to examine the prognostic value and clinical significance of NAT1 methylation in colon adenocarcinoma (COAD). Methods: Data relating to NAT1 mRNA expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Cheng, Xie, Li-ye, Tang, Yan-ping, Long, Long, Li, Ji-lin, Hu, Bang-li, Li, Ke-zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851262/ https://www.ncbi.nlm.nih.gov/pubmed/31781164 http://dx.doi.org/10.3389/fgene.2019.01097

Ejemplares similares

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022)

Evolutionary Genomics Reveals Multiple Functions of Arylalkylamine N-Acetyltransferase in Fish
por: Huang, Yu, et al.
Publicado: (2022)

Identification of N(7)-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma
por: Ma, Xiaomei, et al.
Publicado: (2022)

Construction of a long noncoding RNA-based competing endogenous RNA network and prognostic signatures of left- and right-side colon cancer
por: Li, Ke-zhi, et al.
Publicado: (2021)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma
por: Pan, Shenghua, et al.
Publicado: (2022)

Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma
por: Xiao, Yong, et al.
Publicado: (2021)

Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer
por: Kawakami, K, et al.
Publicado: (2006)

A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy
por: Zhou, Hui, et al.
Publicado: (2023)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
por: Sun, Yuanyuan, et al.
Publicado: (2021)

TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019
por: Luo, Lianxiang, et al.
Publicado: (2020)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Integrative Analysis Reveals Potentially Functional N6-Methylandenosine-Related Long Noncoding RNAs in Colon Adenocarcinoma
por: Tan, Xinjie, et al.
Publicado: (2021)

DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining
por: Chen, Jianlin, et al.
Publicado: (2021)

Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes
por: Xie, Haoran, et al.
Publicado: (2022)

Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma
por: Xiang, Jinyu, et al.
Publicado: (2023)

Characterization of fatty acid metabolism-related lncRNAs in lung adenocarcinoma identifying potential novel prognostic targets
por: Liu, Yang, et al.
Publicado: (2022)

Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity
por: Fukunaga, Koya, et al.
Publicado: (2021)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Analysis of the Prognostic Significance and Immune Infiltration of the Amino Acid Metabolism-Related Genes in Colon Adenocarcinoma
por: Wang, Zhenling, et al.
Publicado: (2022)

Development of necroptosis-related gene signature to predict the prognosis of colon adenocarcinoma
por: Li, Miaomiao, et al.
Publicado: (2022)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis
por: Shen, Na, et al.
Publicado: (2019)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1
por: Kawamura, Akane, et al.
Publicado: (2008)

The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD)
por: Xin, Shiyong, et al.
Publicado: (2022)

Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
por: Liu, Xia, et al.
Publicado: (2022)

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
por: Long, Huan-ping, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bd81m6dqk13sa46sa7sc07r27